WASHINGTON — Whistleblower Rick Bright warned on Thursday that the U.S. lacks a plan to produce and fairly distribute a coronavirus vaccine when it becomes available. The nation could face “the darkest winter in modern history” unless leaders act decisively, he told a congressional panel.
Bright alleges he was ousted from a high-level scientific post after warning the Trump administration to prepare for the pandemic.
Bright said, “We don’t have (a vaccine plan) yet, and it is a significant concern.” Asked if lawmakers should be worried, he responded, “absolutely.”
Bright, a vaccine expert who led a biodefense agency in the Department of Health and Human Services, said the country needs a plan to establish a supply chain for producing tens of millions of doses of a vaccine, and then allocating and distributing them fairly. He said experience so far with an antiviral drug that has been found to benefit COVID-19 patients has not given him much confidence about distribution. Hospital pharmacies have reported problems getting limited supplies.
The White House has begun what it calls “Operation Warp Speed” to quickly produce, distribute and administer a vaccine once it becomes available.
Appearing before the House Energy and Commerce Committee, Bright said one of his lowest moments came when his repeated efforts to jump-start U.S. production of respirator masks went nowhere.
Bright recalled getting emails in late January from Mike Bowen, an executive at a medical supply company called Prestige Ameritech, indicating that our N95 mask supply was “completely decimated.”
- Ex-OpenAI engineer who raised legal concerns about the technology he helped build has died
- Top-ranking NYPD officer abruptly resigns amid sexual misconduct allegations
- France’s Mayotte struggles to recover as cyclone overwhelms hospitals
- 38 people die in a crash between a passenger bus and a truck in Brazil
-
![]()
Germany Christmas market attack: At least 2 dead, dozens injured after man drives car into crowd -
![]()
American diplomat meets with new Syrian leader -
![]()
‘Out of touch’: Mayotte residents criticize Macron’s visit to cyclone-ravaged archipelago -
![]()
Knife attack at Croatia school kills 7-year-old child, injures others
“And he said, ‘We’re in deep shit. The world is. And we need to act,’” Bright said. “And I pushed that forward to the highest levels I could in HHS and got no response. From that moment I knew that we were going to have a crisis for our health care workers because we were not taking action. We were already behind the ball.”
Get weekly health news
Republican lawmakers on the panel for the most part were careful not to attack Bright directly. But Rep. Markwayne Mullins, R-Okla., slammed Bright for continuing to collect his $285,000 salary while first on sick leave for a spike in blood pressure, and now on vacation as he tries to straighten out his work situation.
“You’re too sick to go into work, but you’re well enough to come here while getting paid,” said Mullin. “I have a hard time understanding that.”
A federal watchdog agency has found “reasonable grounds” that Bright was removed from his post as head of the Biomedical Advanced Research and Development Authority after sounding the alarm at the Department of Health and Human Services.
“Our window of opportunity is closing,” Bright said in his prepared testimony. “If we fail to develop a national coordinated response, based in science, I fear the pandemic will get far worse and be prolonged, causing unprecedented illness and fatalities.”
Bright’s testimony follows this week’s warning by Dr. Anthony Fauci, the government’s top infectious disease expert, that a rushed lifting of store-closing and stay-at-home restrictions could “turn back the clock,” seeding more suffering and death and complicating efforts to get the economy rolling again.
U.S. President Donald Trump on Thursday dismissed Bright in a tweet as “a disgruntled employee, not liked or respected by people I spoke to and who, with his attitude, should no longer be working for our government!” It’s a sentiment some of the president’s political allies have expressed about Fauci as well.
More than 84,000 people have died in the U.S., representing more than one-fourth of global deaths and the world’s highest toll, according to figures compiled by Johns Hopkins University. On the planet more than 4.3 million have been infected and about 298,000 have died.
Eager to restart the U.S. economy, Trump has been urging states to lift restrictions, and many governors are doing so gradually, though consumers remain leery of going back to restaurants, social events and sporting competitions.
In his prepared testimony, Bright said, “The undeniable fact is there will be a resurgence of (COVID-19) this fall, greatly compounding the challenges of seasonal influenza and putting an unprecedented strain on our health care system.”
“Without clear planning and implementation of the steps that I and other experts have outlined, 2020 will be darkest winter in modern history,” Bright wrote.
Bright, who has a doctoral degree in immunology, outlined a path forward that would be based on science, even as researchers work to develop better treatments and an effective vaccine. The steps include:
— Establishing a national testing strategy. The White House has urged states to take the lead on testing, even as the federal government pushes to make more tests and better ones widely available. Trump says the U.S. has “prevailed” on testing through this strategy, but in Congress Democrats are demanding a federal framework to encompass the whole nation.
— Doubling down on educating the public about basic safety measures such as frequent hand-washing and wearing masks in public places as guidelines indicate. “Frankly, our leaders must lead by modeling the behavior,” said Bright, in a not-too-subtle reference to a president who conspicuously goes maskless.
— Ramping up production of essential equipment and supplies, from cotton swabs for testing to protective gear for health care workers and essential workers.
— Setting up a system to fairly distribute equipment and supplies that are scarce and highly sought. Eliminating state vs. state competition would increase efficiency and reduce costs, he wrote.
As part of his whistleblower complaint, Bright is seeking to be reinstated in his old job. HHS, his employer, says it strongly disagrees with his allegations and that it reassigned him to a high-profile position helping to lead the development of new coronavirus tests at the National Institutes of Health.
Comments